| Hazard Information | Back Directory | [Uses]
FHT-2344 is a SMARCA4/SMARCA2 ATPase inhibitor with IC50 values of 0.026 μM and 0.013 μM, respectively. FHT-2344 has anticancer activity[1]. | [References]
[1] Centore R C, et al. Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers[J]. bioRxiv, 2023: 2023.09. 11.557162. |
|
|